145 related articles for article (PubMed ID: 2577377)
21. Ebastine in perennial allergic rhinitis.
Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
[TBL] [Abstract][Full Text] [Related]
22. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
[TBL] [Abstract][Full Text] [Related]
23. [Clinical efficacy of Ebastine under placebo-controlled outdoors clinical study on cedar pollinosis].
Asaka H; Yoshida H; Baba K
Arerugi; 2002 Apr; 51(4):357-63. PubMed ID: 12014026
[TBL] [Abstract][Full Text] [Related]
24. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
25. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
[TBL] [Abstract][Full Text] [Related]
26. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
27. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
[TBL] [Abstract][Full Text] [Related]
28. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
Sastre J
J Investig Allergol Clin Immunol; 2020; 30(3):156-168. PubMed ID: 30977465
[TBL] [Abstract][Full Text] [Related]
29. [Ebastine in the treatment of seasonal allergic rhinitis].
Il'ina NI; Balabolkin II; Blokhin BM; Goriachkina LA; Kolganova NA; Pampura AN; Sidorenko IV
Ter Arkh; 1998; 70(9):79-81. PubMed ID: 9821236
[TBL] [Abstract][Full Text] [Related]
30. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
31. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ebastine with cetirizine.
Volkerts ER
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):465-6. PubMed ID: 9396983
[No Abstract] [Full Text] [Related]
33. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.
Camarasa JM; Aliaga A; Fernández-Vozmediano JM; Fonseca E; Iglesias L; Tagarro I
Skin Pharmacol Appl Skin Physiol; 2001; 14(2):77-86. PubMed ID: 11316966
[TBL] [Abstract][Full Text] [Related]
34. Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis.
Conde Hernández DJ; Palma Aqilar JL; Delgado Romero J
Curr Med Res Opin; 1995; 13(6):299-304. PubMed ID: 8829888
[TBL] [Abstract][Full Text] [Related]
35. Ebastine: an update of its use in allergic disorders.
Hurst M; Spencer CM
Drugs; 2000 Apr; 59(4):981-1006. PubMed ID: 10804044
[TBL] [Abstract][Full Text] [Related]
36. Suppression of the skin reaction to histamine by ebastine.
Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
[TBL] [Abstract][Full Text] [Related]
37. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
Frossard N; Melac M; Benabdesselam O; Pauli G
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
39. Effect of ebastine on mosquito bites.
Reunala T; Brummer-Korvenkontio H; Petman L; Palosuo T; Sarna S
Acta Derm Venereol; 1997 Jul; 77(4):315-6. PubMed ID: 9228228
[TBL] [Abstract][Full Text] [Related]
40. Overview of allergic mechanisms. Ebastine has more than an antihistamine effect.
Campbell A; Michel FB; Bremard-Oury C; Crampette L; Bousquet J
Drugs; 1996; 52 Suppl 1():15-9. PubMed ID: 8983912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
